The writer of most these publications can be Adeonas scientific founder and consultant.

Brewer raises the important questions in his editorial, ‘why has there by no means been a formal toxicity research of copper in drinking water, some developed countries embrace home copper plumbing, using its copper leaching problems?’ and ‘with all the current evidence emerging within the last six years, why are pharmaceutical and neutraceutical companies continuing to put large amounts of copper within their supplement pills, and just why are they permitted to do therefore?’ The fourth publication entitled, ‘Dangers of Copper and Iron Toxicity During Ageing in Humans’, on December 7 was published in digital form, 2009 in Chemical Research in Toxicology.The data were gathered and analyzed and the trial was monitored by the Intracoronary Stenting and Antithrombosis Study Middle, which is associated with Deutsches Herzzentrum, Munich, Germany. Nycomed Pharma, the previous distributor of bivalirudin in Europe and among the sponsors of the study, had no part in the design of the study; the collection, evaluation, or interpretation of the info; the composing of the manuscript; or the decision to send the manuscript for publication. No agreement exists between the authors and this company with respect to confidentiality of the data. The first author wrote the first draft of the manuscript.